STAT3 and glioblastoma: According to Lee et al., high MGO doses reduce the crucial cell survival signaling pathway, gp130/STAT3, leading to an increased cytotoxicity in rat schwannoma RT4 cells, PC12 cells, and U87MG GBM cells.